GSK Korea target 250 billion sales revenue this year

GlaxoSmithKline Korea said that it is aiming for a 250 billion won in sales revenue this year, up 1.2 percent against sales revenue of 220 billion won in 2003.

To that end, the company said it selected 11 unit heads involved in each therapeutic category (including wholesaling business) at the end of last year, ensuring more activated communication between internal different units and respo...